These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28407520)

  • 21. The cognitive effects of anticholinergic drugs on apolipoprotein ε4 carriers and noncarriers in the Wisconsin Registry for Alzheimer's Prevention study.
    Collin BG; Raju D; Katsikas S
    Neuropsychology; 2021 Feb; 35(2):220-231. PubMed ID: 33764112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The trajectory of cognitive decline in the pre-dementia phase in memory clinic visitors: findings from the 4C-MCI study.
    Hamel R; Köhler S; Sistermans N; Koene T; Pijnenburg Y; van der Flier W; Scheltens P; Aalten P; Verhey F; Visser PJ; Ramakers I
    Psychol Med; 2015 May; 45(7):1509-19. PubMed ID: 25407094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of multiple low-level anticholinergic medications on anticholinergic load of community-dwelling elderly with and without dementia.
    Mate KE; Kerr KP; Pond D; Williams EJ; Marley J; Disler P; Brodaty H; Magin PJ
    Drugs Aging; 2015 Feb; 32(2):159-67. PubMed ID: 25566958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations Between Midlife Anticholinergic Medication Use and Subsequent Cognitive Decline: A British Birth Cohort Study.
    Rawle MJ; Lau WCY; Gonzalez-Izquierdo A; Patalay P; Richards M; Davis D
    Drugs Aging; 2024 Jun; 41(6):543-554. PubMed ID: 38740716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
    J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentially inappropriate anticholinergic medication use in older adults with dementia.
    Kachru N; Carnahan RM; Johnson ML; Aparasu RR
    J Am Pharm Assoc (2003); 2015; 55(6):603-612. PubMed ID: 26501745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.
    Dauphinot V; Mouchoux C; Veillard S; Delphin-Combe F; Krolak-Salmon P
    Alzheimers Res Ther; 2017 Aug; 9(1):58. PubMed ID: 28764796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.
    Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Wolfe R; Connors MH; Elliott RA
    J Alzheimers Dis; 2017; 60(2):349-358. PubMed ID: 28869467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
    Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
    Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semantic item-level metrics relate to future memory decline beyond existing cognitive tests in older adults without dementia.
    Vonk JMJ; Geerlings MI; Avila-Rieger JF; Qian CL; Schupf N; Mayeux R; Brickman AM; Manly JJ
    Psychol Aging; 2023 Aug; 38(5):443-454. PubMed ID: 37199965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study.
    Ancelin ML; Artero S; Portet F; Dupuy AM; Touchon J; Ritchie K
    BMJ; 2006 Feb; 332(7539):455-9. PubMed ID: 16452102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal associations of anticholinergic medications on cognition and possible mitigating role of physical activity.
    Norling AM; Bennett A; Crowe M; Long DL; Nolin SA; Myers T; Del Bene VA; Lazar RM; Gerstenecker A
    J Am Geriatr Soc; 2023 Jun; 71(6):1937-1943. PubMed ID: 36786273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global Vascular Risk Score and CAIDE Dementia Risk Score Predict Cognitive Function in the Northern Manhattan Study.
    Rundek T; Gardener H; Dias Saporta AS; Loewenstein DA; Duara R; Wright CB; Dong C; Levin B; Elkind MSV; Sacco RL
    J Alzheimers Dis; 2020; 73(3):1221-1231. PubMed ID: 31884476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
    Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
    Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
    Andre L; Gallini A; Montastruc F; Coley N; Montastruc JL; Vellas B; Andrieu S; Gardette V;
    Br J Clin Pharmacol; 2019 Jan; 85(1):71-99. PubMed ID: 30098049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term anticholinergic, benzodiazepine and Z-drug use in community-dwelling older adults: What is the impact on cognitive and neuropsychological performance?
    Dyer AH; Laird E; Hoey L; Hughes CF; McNulty H; Ward M; Strain JJ; Molloy AM; Cunningham C; McCarroll K
    Int J Geriatr Psychiatry; 2021 Nov; 36(11):1767-1777. PubMed ID: 34227695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women.
    Cao YJ; Mager DE; Simonsick EM; Hilmer SN; Ling SM; Windham BG; Crentsil V; Yasar S; Fried LP; Abernethy DR
    Clin Pharmacol Ther; 2008 Mar; 83(3):422-9. PubMed ID: 17713474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
    Andre L; Gallini A; Montastruc F; Montastruc JL; Piau A; Lapeyre-Mestre M; Gardette V
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1631-1644. PubMed ID: 31468067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticholinergic effect on cognition (AEC) of drugs commonly used in older people.
    Bishara D; Harwood D; Sauer J; Taylor DM
    Int J Geriatr Psychiatry; 2017 Jun; 32(6):650-656. PubMed ID: 27280553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Cumulative Anticholinergic Use on the Cognitive Function of Older Adults: Results from the Personality and Total Health (PATH) Through Life Study.
    Neelamegam M; Zgibor J; Chen H; O'rourke K; Bakour C; Rajaram L; Anstey KJ
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):1706-1714. PubMed ID: 32514523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.